楓葉教育(01317.HK):入讀學生總數達44,338名學生 同比增長6.8%
格隆匯 10 月 16日丨楓葉教育(01317.HK)發佈公告,截至2020年10月15日,楓葉學校的入讀學生總數約為44,338名學生,較去年同期增長6.8%。
董事會認為,本學年上學期入讀學生人數增長遜於去年同期的主要原因為:(1)受海外疫情及地緣政治等綜合影響,中國學生及家長對出國留學持觀望態度;及(2)楓葉海外校區所在國家因疫情所採取的的邊境和簽證限制,部分新生無法入學。
隨着以上因素在本學年第二學期得到改善(包括解除邊境管制),董事會對第二學期入讀學生人數增長並最終達成六五規劃的入讀人數目標保持樂觀。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.